Attached files
| file | filename |
|---|---|
| EX-99.4 - EXHIBIT 99.4 - PTC THERAPEUTICS, INC. | form8-ka42017xexhibit994.htm |
| EX-99.3 - EXHIBIT 99.3 - PTC THERAPEUTICS, INC. | form8-ka42017xexhibit993.htm |
| EX-99.2 - EXHIBIT 99.2 - PTC THERAPEUTICS, INC. | form8-ka42017xexhibit992.htm |
| 8-K/A - 8-K/A - PTC THERAPEUTICS, INC. | form8-ka42017.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in Registration Statement No. 333-194323, No. 333-189962, No. 333-203485, No. 333-208830, No. 333-211997, and 333-215407 on Form S-8 of PTC Therapeutics, Inc. of our report dated May 10, 2017, relating to the financial statements of the Emflaza Business appearing in this Current Report on Form 8-K/A dated July 3, 2017 of PTC Therapeutics, Inc.
/s/ Deloitte & Touche LLP
Chicago, Illinois
July 3, 2017